BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells
Simona Camero, Lucrezia Camicia, Francesco Marampon, Simona Ceccarelli, Rajeev Shukla, Olga Mannarino, Barry Pizer, Amalia Schiavetti, Antonio Pizzuti, Vincenzo Tombolini, Cinzia Marchese, Carlo Dominici, Francesca Megiorni
Topics & Concepts
RhabdomyosarcomaClonogenic assayCancer researchRadioresistanceBiologyCancer cellCancerDownregulation and upregulationBromodomainBET inhibitorCellCell cultureSarcomaMedicineGeneEpigeneticsPathologyGeneticsProtein Degradation and InhibitorsSarcoma Diagnosis and TreatmentCancer-related gene regulation